Original Research
Accepted on 26 Jul 2024
Optimizing First-Line TKI Treatment Efficacy in PD-L1-Positive EGFR-Mutated NSCLC: The Impact of Antiangiogenic Agents
in Pharmacology of Anti-Cancer Drugs
Original Research
Accepted on 26 Jul 2024
in Pharmacology of Anti-Cancer Drugs
Review
Accepted on 26 Jul 2024
in Experimental Pharmacology and Drug Discovery
Editorial
Accepted on 26 Jul 2024
in General Cardiovascular Medicine
Original Research
Accepted on 26 Jul 2024
in Health Communication
Original Research
Accepted on 26 Jul 2024
in Biomedical Robotics
Original Research
Accepted on 26 Jul 2024
in Biomedical Robotics
Review
Accepted on 26 Jul 2024
in Metamaterials
Original Research
Accepted on 26 Jul 2024
in Teacher Education
Original Research
Accepted on 26 Jul 2024
in Molecular Psychiatry
Review
Accepted on 26 Jul 2024
in Nutritional Immunology
Editorial
Accepted on 26 Jul 2024
in General Cardiovascular Medicine
Original Research
Accepted on 26 Jul 2024
in Cancer Immunity and Immunotherapy
Brief Research Report
Accepted on 26 Jul 2024
in Psychology for Clinical Settings
Mini Review
Accepted on 26 Jul 2024
in Cancer Immunity and Immunotherapy
Original Research
Accepted on 26 Jul 2024
in Space Physics
Original Research
Accepted on 26 Jul 2024
in Public Mental Health